Risk adjusted net present value: What is the current valuation of Merck’s MK-1084?

Teladoc’s chief op­er­at­ing of­fi­cer has re­signed due to an ex­ec­u­tive reshuf­fle, a few months af­ter the com­pa­ny named a new CEO. COO Michael Wa­ters’ res­ig­na­tion

The FDA has high­light­ed de­vi­a­tions from cur­rent good man­u­fac­tur­ing prac­tice for MiMedx’s Ax­iofill, a pla­cen­ta-based prod­uct which is un­der re­view re­gard­ing its le­gal clas­si­fi­ca­tion. Af­ter